FEED ENvue Medical, Inc. - Common Stock
$0,43
Fiyat · Ağu 19, 2026
Temel veriler itibarıyla Ağu 17, 2026
52 Haftlık Aralık
$0–$17
1% of range
Analist Derecelendirmesi
BUY
7 analysts
Fiyat Hedefi
—
P/E (TTM)
-0.0
ROE
-49.2%
Net Kâr Marjı
-712.3%
FEED Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$0.43
Piyasa Değeri
$471.1K
P/E (TTM)
-0.0
EPS (TTM)
$-26.69
Gelir (TTM)
$3M
Temettü Verimi
—
ROE
-49.2%
D/E Borç/Özsermaye
—
52 Haftlık Aralık
$0 – $17
FEED Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
Configure
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir ve Net Gelir
$3M
2016-12-31
→
2025-12-31
Hisse Başına Kâr
$-26.69
2022-12-31
→
2025-12-31
Serbest Nakit Akışı
$-9M
2016-12-31
→
2025-12-31
Marjlar
-712.3%
2016-12-31
→
2025-12-31
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
Metrik
5 Yıllık trend
FEED
Akran Ortalaması
P/E (TTM)
-0.0
27.5
P/S (TTM) (F/S (TTM))
0.2
1.1
P/B (F/D)
0.0
1.6
Price / FCF (Fiyat / Serbest Nakit Akışı)
-0.0
—
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
Metrik
5 Yıllık trend
FEED
Akran Ortalaması
Gross Margin (Brüt Kar Marjı)
6.0%
47.8%
Operating Margin (Faaliyet Kâr Marjı)
-896.6%
—
Net Profit Margin (Net Kâr Marjı)
-712.3%
-425.0%
ROA
-81.3%
-110.2%
ROE
-49.2%
-269.2%
ROIC
-67.2%
—
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
Metrik
5 Yıllık trend
FEED
Akran Ortalaması
Current Ratio (Cari Oran)
1.1
1.5
Quick Ratio (Cari Oran)
0.7
—
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Metrik
5 Yıllık trend
FEED
Akran Ortalaması
Revenue YoY (Gelir Yıllık Bazda)
-0.20%
—
Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı)
50.3%
—
Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı)
32.6%
—
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Metrik
5 Yıllık trend
FEED
Akran Ortalaması
FEED Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
AL
7 analist
- Güçlü Al 2 28,6%
- Al 4 57,1%
- Tut 1 14,3%
- Sat 0 0,0%
- Güçlü Sat 0 0,0%
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
81.5%
| Dönem | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|
| 30 Haziran 2026 | $-1.98 | — | — |
| 31 Mart 2026 | $-6.88 | — | — |
| 30 Eylül 2023 | $-0.42 | — | — |
| 30 Eylül 2019 | $-264.00 | $-448.80 | 184.8% |
| 30 Haziran 2019 | $-352.00 | $-448.80 | 96.8% |
| 31 Aralık 2018 | $-396.00 | $-359.04 | -37.0% |
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| FEED | $3M | -0.1 | -0.20% | -712.3% | -49.2% | 6.0% |
| INBS | $13M | -0.9 | -1.9% | -346.2% | -186.6% | 40.8% |
| AMIX | — | — | — | — | — | — |
| BMRA | — | -1.4 | -1.9% | — | — | — |
| NUWE | $3M | -0.1 | -5.4% | -211.9% | 553.1% | 62.0% |
| BJDX | $403.2K | -0.0 | — | — | -121.6% | — |
| XAIR | $8M | -0.2 | 107.3% | -433.0% | -337.4% | 3.3% |
| GCTK | $4M | 0.1 | — | — | -399.4% | — |
| PFSA | $129.4K | -0.0 | — | — | 47.5% | — |
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | — |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu 16
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3M | $3M | $2M | $752.0K | $2M | $623.0K | $530.0K | $318.0K | $239.0K | $229.0K | $147.0K | $203.0K | |
| Cost of Revenue | $2M | $1M | $746.0K | $585.0K | $925.0K | $409.0K | $249.0K | $158.0K | $88.0K | $88.0K | $49.0K | $93.0K | |
| Gross Profit | $153.0K | $2M | $2M | $167.0K | $770.0K | $214.0K | $281.0K | $160.0K | $151.0K | $141.0K | $98.0K | $110.0K | |
| R&D Expense | $2M | $909.0K | $185.0K | $283.0K | $293.0K | $171.0K | $514.0K | $614.0K | $693.0K | $584.0K | $399.0K | $431.0K | |
| SG&A Expense | $8M | $3M | $4M | $4M | $5M | $4M | $4M | $3M | $2M | $1M | $746.0K | $589.0K | |
| Operating Expenses | $23M | $5M | $5M | $5M | $6M | $5M | $5M | $4M | $3M | $2M | $2M | $1M | |
| Operating Income | $-23M | $-4M | $-3M | $-5M | $-6M | $-5M | $-5M | $-4M | $-3M | $-2M | $-1M | $-1M | |
| Interest Expense | · | $135.0K | $135.0K | $347.0K | · | $147.0K | $15.0K | · | · | · | · | · | |
| Pretax Income | $-18M | $-4M | $-4M | $-5M | $-14M | $-4M | $-6M | $-4M | $-5M | $-3M | $-3M | $-3M | |
| Income Tax | $-307.0K | $19.0K | $29.0K | $35.0K | $32.0K | $15.0K | $-17.0K | $-127.0K | $38.0K | $117.0K | $28.0K | $49.0K | |
| Net Income | $-18M | $-4M | $-4M | $-5M | $-14M | $-4M | $-6M | $-4M | $-5M | $-3M | $-3M | $-3M | |
| EPS (Basic) | $-26.69 | $-137.30 | $-23.32 | $-3.84 | $-11.35 | · | · | · | · | · | · | · | |
| EPS (Diluted) | $-26.69 | $-137.30 | $-23.32 | $-3.84 | · | · | · | · | · | · | · | · | |
| Shares (Basic) | 628,534 | 26,985 | 159,105 | 1,419,670 | 1,258,141 | · | · | · | · | · | · | · | |
| Shares (Diluted) | 628,534 | 26,985 | 159,105 | 1,419,670 | · | · | · | · | · | · | · | · | |
| EBITDA | $-22M | $-4M | · | $-5M | · | $-5M | $-5M | $-4M | $-3M | $-2M | $-1M | · |
Bilanço 25
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4M | $752.0K | $3M | $3M | $8M | $7M | $1M | $896.0K | $4M | $106.0K | $2M | $90.0K | |
| Receivables | $289.0K | $98.0K | $318.0K | $9.0K | $200.0K | $25.0K | $111.0K | $95.0K | $24.0K | $6.0K | $5.0K | $21.0K | |
| Inventory | $2M | $2M | $3M | $2M | $175.0K | $145.0K | $121.0K | $144.0K | $76.0K | $67.0K | $71.0K | $35.0K | |
| Prepaid Expense | $137.0K | $120.0K | $154.0K | $712.0K | $230.0K | $267.0K | $268.0K | $95.0K | $61.0K | $42.0K | $86.0K | $19.0K | |
| Other Current Assets | $254.0K | $170.0K | $107.0K | $100M | $64.0K | $68.0K | $19.0K | $49.0K | · | · | · | · | |
| Current Assets | $7M | $3M | $6M | $6M | $8M | $8M | $2M | $1M | $5M | $221.0K | $2M | $165.0K | |
| PP&E (Net) | $119.0K | $9.0K | $7.0K | $7.0K | $5.0K | $4.0K | $4.0K | $8.0K | $5.0K | $11.0K | $10.0K | $18.0K | |
| PP&E (Gross) | · | · | · | · | · | · | $58.0K | $58.0K | $50.0K | $51.0K | $110.0K | $109.0K | |
| Accum. Depreciation | · | · | · | · | · | · | $54.0K | $50.0K | $-45.0K | $40.0K | $100.0K | $91.0K | |
| Goodwill | $29M | · | · | · | · | · | · | · | · | · | · | · | |
| Intangibles | $4M | · | · | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | · | · | $1.0K | $3.0K | $19.0K | $25.0K | · | · | · | · | · | · | |
| Total Assets | $41M | $4M | $7M | $6M | $9M | $8M | $2M | $2M | $5M | $494.0K | $2M | $723.0K | |
| Accounts Payable | $719.0K | $47.0K | $138.0K | $66.0K | $87.0K | $144.0K | $129.0K | $193.0K | $168.0K | $82.0K | $58.0K | $101.0K | |
| Accrued Liabilities | · | · | · | · | · | · | · | $123.0K | $150.0K | $99.0K | $47.0K | $551.0K | |
| Current Liabilities | $7M | $3M | $2M | $2M | $2M | $3M | $409.0K | $640.0K | $797.0K | $565.0K | $297.0K | $5M | |
| Capital Leases | $28.0K | $64.0K | · | · | · | $18.0K | · | · | · | · | · | · | |
| Total Liabilities | $8M | $3M | $3M | $3M | $2M | $6M | $688.0K | $1M | · | · | · | · | |
| Common Stock | $1.0K | $1.0K | $2.0K | $2.0K | $1.0K | $22.0K | $5.0K | $4.0K | $4.0K | $2.0K | $2.0K | · | |
| Paid-in Capital | $124M | $71M | $70M | $66M | $63M | $45M | $40M | $33M | $32M | $20M | $20M | $11M | |
| Retained Earnings | $-90M | $-70M | $-66M | $-62M | $-57M | $-43M | $-38M | $-33M | $-28M | $-23M | $-20M | $-17M | |
| AOCI | $-80.0K | $-80.0K | $-67.0K | $-18.0K | $60.0K | $66.0K | · | · | · | · | · | · | |
| Stockholders' Equity | $33M | $627.0K | $4M | $3M | $6M | $2M | $1M | $463.0K | $4M | $-2M | $-209.0K | $-6M | |
| Liabilities + Equity | $41M | $4M | $7M | $6M | $9M | $8M | $2M | $2M | $5M | $494.0K | $2M | $723.0K | |
| Shares Outstanding | 1,100,413 | 37,894 | 186,028 | 1,641,146 | 1,399,890 | 21,246,523 | 4,203,764 | 3,801,522 | 3,935,865 | 2,632,710 | 2,611,328 | 163,580 |
Nakit Akışı 17
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $897.0K | $1.0K | $1.0K | $1.0K | $2.0K | $2.0K | $4.0K | $6.0K | · | · | · | · | |
| Stock-based Comp | · | $356.0K | $293.0K | $354.0K | $382.0K | $376.0K | $2M | $889.0K | $800.0K | $508.0K | $220.0K | $24.0K | |
| Deferred Tax | $-373.0K | · | $-1M | $-893M | $-1M | $-587.0K | $-2M | $-1M | · | · | · | · | |
| Amort. of Intangibles | $855.0K | · | · | · | · | · | · | · | · | · | · | · | |
| Other Non-cash | $8M | $2M | · | $-1M | · | $1M | $2M | · | · | · | · | · | |
| Operating Cash Flow | $-9M | $-3M | $-4M | $-7M | $-4M | $-3M | $-4M | $-4M | $-2M | $-2M | $-1M | $-900.0K | |
| CapEx | $60.0K | $3.0K | $1.0K | $3.0K | $3.0K | $2.0K | · | $8.0K | · | $8.0K | $1.0K | $4.0K | |
| Investing Cash Flow | $88.0K | $-3.0K | $-1.0K | $-3.0K | $-3.0K | $-2.0K | · | $-8.0K | · | $-8.0K | · | · | |
| Debt Issued | $1M | · | · | · | · | · | · | · | · | · | · | · | |
| Net Debt Issued | $1M | · | · | · | · | · | · | · | · | · | · | · | |
| Stock Issued | · | · | $4M | $2M | · | $9M | $630.0K | · | · | · | · | · | |
| Net Stock Activity | · | · | · | $2M | · | $9M | $630.0K | · | · | · | · | · | |
| Financing Cash Flow | $13M | $1.0K | $4M | $2M | $5M | $10M | $4M | $94.0K | $6M | $33.0K | · | · | |
| Net Change in Cash | $4M | $-3M | $570.0K | $-5M | $204.0K | $6M | $442.0K | $-3M | $4M | $-2M | $2M | $-4.0K | |
| Taxes Paid | $52.0K | · | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-9M | $-3M | · | $-7M | · | $-3M | · | $-4M | · | $-2M | $-1M | · | |
| Levered FCF | · | $-3M | · | $-7M | · | $-4M | · | · | · | · | · | · |
Kârlılık 8
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 6.0% | 59.0% | · | 22.2% | · | 34.4% | 53.0% | 50.3% | 63.2% | 61.6% | 66.7% | · | |
| Operating Margin | -896.6% | -140.0% | · | -666.5% | · | -757.5% | -971.9% | -1353.1% | -1293.3% | -1011.4% | -968.7% | · | |
| Net Margin | -712.3% | -144.8% | · | -724.5% | · | -694.2% | -1093.2% | -1306.3% | -2077.4% | -1236.2% | -1961.9% | · | |
| Pretax Margin | -724.3% | -144.1% | · | -719.8% | · | -692.0% | -1096.4% | -1346.2% | -2061.5% | -1185.1% | -1942.9% | · | |
| EBITDA Margin | -861.4% | -140.0% | · | -666.4% | · | -757.1% | -971.1% | -1353.1% | -1293.3% | -1011.4% | -968.7% | · | |
| ROA | -81.3% | -71.9% | · | -75.1% | · | -84.3% | -320.5% | -128.9% | -185.3% | · | -213.2% | · | |
| ROE | -49.2% | -296.5% | · | -170.6% | · | -152.8% | -323.9% | -202.8% | -874.9% | · | -28840.0% | · | |
| ROIC | -67.2% | -574.2% | · | -156.0% | · | -197.8% | -381.0% | -901.8% | -85.7% | · | 688.0% | · |
Likidite ve Solventlik 3
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.1 | 1.2 | · | 2.4 | · | 2.7 | 4.5 | 1.9 | 5.7 | · | 6.0 | · | |
| Quick Ratio | 0.7 | 0.3 | · | 1.2 | · | 2.5 | 3.5 | 1.5 | 5.5 | · | 5.5 | · | |
| Interest Coverage | · | -26.5 | · | -14.4 | · | -32.1 | -343.4 | · | · | · | · | · |
Verimlilik 3
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.5 | · | 0.1 | · | 0.1 | 0.3 | 0.1 | 0.1 | · | 0.1 | · | |
| Inventory Turnover | 1.1 | 0.4 | · | 0.5 | · | 3.1 | 1.9 | 1.4 | 1.2 | · | 0.9 | · | |
| Receivables Turnover | 13.2 | 12.3 | · | 7.2 | · | 9.2 | 5.1 | 5.3 | 15.9 | · | 11.3 | · |
Büyüme Oranları 3
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -0.20% | 12.0% | 203.6% | -55.6% | 172.1% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 50.3% | 14.7% | 54.2% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 32.6% | · | · | · | · | · | · | · | · | · | · | · |
Değerleme (TTM) 10
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $3M | $3M | $2M | $752.0K | $2M | $623.0K | $530.0K | $318.0K | $239.0K | $229.0K | $147.0K | $203.0K | |
| Net Income TTM | $-18M | $-4M | $-4M | $-5M | $-14M | $-4M | $-6M | $-4M | $-5M | $-3M | $-3M | $-3M | |
| Market Cap | $3M | $25M | · | · | · | · | · | · | · | · | · | · | |
| P/E | -0.1 | -0.5 | · | · | · | · | · | · | · | · | · | · | |
| P/S | 1.0 | 9.6 | · | · | · | · | · | · | · | · | · | · | |
| P/B | 0.1 | 39.2 | · | · | · | · | · | · | · | · | · | · | |
| P / Tangible Book | 72.6 | 39.2 | · | · | · | · | · | · | · | · | · | · | |
| P / Cash Flow | -0.3 | -9.8 | · | · | · | · | · | · | · | · | · | · | |
| P / FCF | -0.3 | -9.8 | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -1155.4% | -211.6% | · | · | · | · | · | · | · | · | · | · |
Gelir Tablosu 16
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $239.0K | $653.0K | $312.0K | $722.0K | $494.0K | $1M | $444.0K | $376.0K | $817.0K | $921.0K | $1M | $458.0K | $294.0K | $354.0K | $-102.0K | $97.0K | |
| Cost of Revenue | $505.0K | $708.0K | $682.0K | $533.0K | $529.0K | $656.0K | $161.0K | $243.0K | $389.0K | $257.0K | $440.0K | $109.0K | $78.0K | $119.0K | $198.0K | $17.0K | |
| Gross Profit | $-266.0K | $-55.0K | $-370.0K | $189.0K | $-35.0K | $369.0K | $283.0K | $133.0K | $428.0K | $664.0K | $737.0K | $349.0K | $216.0K | $235.0K | $-300.0K | $80.0K | |
| R&D Expense | $510.0K | $468.0K | $39.0K | $221.0K | $1M | $530.0K | $352.0K | $249.0K | $187.0K | $121.0K | $62.0K | $33.0K | $35.0K | $55.0K | $107.0K | $49.0K | |
| SG&A Expense | $4M | $2M | $3M | $1M | $2M | $1M | $1M | $673.0K | $716.0K | $946.0K | $1M | $796.0K | $963.0K | $1M | $1M | $738.0K | |
| Operating Expenses | $5M | $4M | $14M | $2M | $4M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| Operating Income | $-5M | $-4M | $-15M | $-2M | $-4M | $-2M | $-1M | $-970.0K | $-674.0K | $-568.0K | $-702.0K | $-670.0K | $-1M | $-1M | $-2M | $-924.0K | |
| Interest Expense | · | · | · | · | $144.0K | $53.0K | · | $33.0K | $34.0K | $34.0K | $33.0K | $35.0K | $33.0K | $34.0K | · | · | |
| Pretax Income | $-5M | $-4M | $-13M | $545.0K | $-4M | $-2M | $-1M | $-995.0K | $-684.0K | $-581.0K | $-802.0K | $-724.0K | $-1M | $-1M | $-2M | $-940.0K | |
| Income Tax | $-2.0K | $33.0K | $-419.0K | $35.0K | $62.0K | $15.0K | $5.0K | $3.0K | $4.0K | $7.0K | $11.0K | $3.0K | $13.0K | $2.0K | $-3.0K | $15.0K | |
| Net Income | $-5M | $-4M | $-12M | $510.0K | $-4M | $-2M | $-1M | $-998.0K | $-688.0K | $-588.0K | $-813.0K | $-727.0K | $-1M | $-1M | $-2M | $-955.0K | |
| EPS (Basic) | $-1.98 | $-6.88 | $-20.00 | $-0.91 | $-1.03 | $-29.90 | $-108.94 | $-3.56 | $-27.18 | $2.38 | $-21.58 | $-0.42 | $-0.65 | $-0.67 | $-1.42 | $-0.68 | |
| EPS (Diluted) | $-1.98 | $-6.88 | $-28.73 | $-0.91 | $-1.03 | $-29.90 | $-108.94 | $-3.56 | $-27.18 | $2.38 | $-21.58 | $-0.42 | $-0.65 | $-0.67 | $-1.42 | $-0.68 | |
| Shares (Basic) | 6,157,249 | 3,289,049 | -1,340,616 | 858,434 | 484,566 | 62,615 | -525,625 | 280,318 | 25,312 | 246,980 | -4,876,187 | 1,721,026 | 1,662,330 | 1,651,936 | -2,780,000 | 1,399,890 | |
| Shares (Diluted) | 6,157,249 | 3,289,049 | -1,340,616 | 858,434 | 484,566 | 62,615 | -525,625 | 280,318 | 25,312 | 246,980 | -4,876,187 | 1,721,026 | 1,662,330 | 1,651,936 | 19,780 | 1,399,890 | |
| EBITDA | $-5M | $-3M | · | $-2M | $-4M | $-2M | · | $-970.0K | $-674.0K | $-568.0K | · | $-670.0K | $-1M | $-1M | · | $-924.0K |
Bilanço 23
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1M | $2M | $4M | $7M | $4M | $601.0K | $752.0K | $1M | $2M | $3M | $3M | $4M | $253.0K | $2M | $3M | $2M | |
| Receivables | $205.0K | $332.0K | $289.0K | $252.0K | $115.0K | $358.0K | $98.0K | $580.0K | $489.0K | $360.0K | $318.0K | $32.0K | $71.0K | $58.0K | $9.0K | $226.0K | |
| Inventory | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | |
| Prepaid Expense | $598.0K | $941.0K | $137.0K | $540.0K | $511.0K | $881.0K | $120.0K | $242.0K | $296.0K | $297.0K | $154.0K | $170.0K | $176.0K | $782.0K | $712.0K | $1M | |
| Other Current Assets | $293.0K | $393.0K | $254.0K | · | · | · | $170.0K | · | · | · | $107.0K | · | · | · | $100M | · | |
| Current Assets | $5M | $6M | $7M | $10M | $7M | $4M | $3M | $4M | $5M | $6M | $6M | $7M | $4M | $5M | $6M | $5M | |
| PP&E (Net) | $145.0K | $127.0K | $119.0K | $124.0K | $112.0K | $125.0K | $9.0K | $9.0K | $9.0K | $8.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $8.0K | |
| Goodwill | $29M | $29M | $29M | $39M | $39M | $34M | · | · | · | · | · | · | · | · | · | · | |
| Intangibles | $4M | $4M | $4M | $5M | $6M | $6M | · | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | · | · | · | · | · | · | · | · | $1.0K | $1.0K | $1.0K | $2.0K | $3.0K | $5.0K | $3.0K | $7.0K | |
| Total Assets | $38M | $40M | $41M | $54M | $51M | $44M | $4M | $5M | $6M | $6M | $7M | $7M | $4M | $5M | $6M | $5M | |
| Accounts Payable | $839.0K | $706.0K | $719.0K | $492.0K | $270.0K | $149.0K | $47.0K | $25.0K | $92.0K | $37.0K | $138.0K | $62.0K | $33.0K | $45.0K | $66.0K | $41.0K | |
| Current Liabilities | $7M | $7M | $7M | $12M | $7M | $8M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Capital Leases | $68.0K | $35.0K | $28.0K | $15.0K | $69.0K | $17.0K | $64.0K | $77.0K | $89.0K | $86.0K | · | · | · | · | · | · | |
| Total Liabilities | $8M | $8M | $8M | $12M | $11M | $8M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | |
| Long-term Debt | · | · | · | · | · | $1M | · | · | · | · | · | · | · | · | · | · | |
| Common Stock | $8.0K | $4.0K | $1.0K | $1.0K | $8.0K | $1.0K | $1.0K | $3.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $28.0K | |
| Paid-in Capital | $155M | $144M | $124M | $119M | $117M | $108M | $71M | $70M | $70M | $70M | $70M | $70M | $66M | $66M | $66M | $63M | |
| Retained Earnings | $-124M | $-112M | $-90M | $-77M | $-76M | $-72M | $-70M | $-68M | $-67M | $-67M | $-66M | $-65M | $-65M | $-63M | $-62M | $-60M | |
| AOCI | $-80.0K | $-80.0K | $-80.0K | $-87.0K | $-85.0K | $-81.0K | $-80.0K | $-75.0K | $-73.0K | $-70.0K | $-67.0K | $-54.0K | $-55.0K | $-25.0K | $-18.0K | $3.0K | |
| Stockholders' Equity | $31M | $32M | $33M | $42M | $40M | $36M | $627.0K | $2M | $3M | $4M | $4M | $5M | $1M | $2M | $3M | $3M | |
| Liabilities + Equity | $38M | $40M | $41M | $54M | $51M | $44M | $4M | $5M | $6M | $6M | $7M | $7M | $4M | $5M | $6M | $5M | |
| Shares Outstanding | 8,194,387 | 3,700,908 | 1,100,413 | 1,011,086 | 787,359 | 734,025 | 37,894 | 2,784,353 | 2,784,353 | 2,784,353 | 186,028 | 1,842,331 | 1,662,330 | 1,662,330 | 1,641,146 | 27,997,793 |
Nakit Akışı 13
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $219.0K | $217.0K | $258.0K | $257.0K | $364.0K | $18.0K | $0 | $0 | · | · | $0 | $0 | $0 | $1.0K | $0 | · | |
| Stock-based Comp | · | · | · | · | · | · | $191.0K | $58.0K | $0 | $107.0K | $124.0K | $36.0K | $66.0K | $67.0K | $67.0K | $-19.0K | |
| Amort. of Intangibles | $209.0K | $210.0K | · | · | $347.0K | $17.0K | · | · | · | · | · | · | · | · | · | · | |
| Other Non-cash | · | $-707.0K | · | · | · | $1M | · | · | · | · | · | · | · | $-171.0K | · | · | |
| Operating Cash Flow | $-3M | $-4M | $-3M | $-2M | $-3M | $-1M | $-548.0K | $-836.0K | $-553.0K | $-579.0K | $-491.0K | $-682.0K | $-1M | $-1M | $-1M | $-2M | |
| CapEx | $27.0K | $17.0K | $23.0K | $28.0K | $4.0K | $5.0K | $0 | $0 | $2.0K | $1.0K | $0 | $0 | $0 | $1.0K | $-1.0K | $2.0K | |
| Investing Cash Flow | $-27.0K | $-17.0K | $-23.0K | $-28.0K | $-4.0K | $143.0K | $0 | $0 | $-2.0K | $-1.0K | $0 | $0 | $0 | $-1.0K | $1.0K | $-2.0K | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | $0 | · | · | · | · | · | |
| Financing Cash Flow | $2M | $2M | $-34.0K | $5M | $7M | $1M | $0 | $-27.0K | · | · | $0 | $4M | $0 | $7.0K | · | · | |
| Net Change in Cash | $-1M | $-2M | $-3M | $3M | $3M | $-151.0K | $-553.0K | $-865.0K | $-530.0K | $-583.0K | $-504.0K | $4M | $-1M | $-1M | $741.0K | $-2M | |
| Taxes Paid | $3.0K | $1.0K | $32.0K | $13.0K | · | · | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | · | $-4M | · | · | · | $-1M | · | · | · | $-580.0K | · | · | · | $-1M | · | · | |
| Levered FCF | · | · | · | · | · | $-1M | · | · | · | $-614.4K | · | · | · | $-1M | · | · |
Kârlılık 8
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | -111.3% | -8.4% | · | 26.2% | -7.1% | 36.0% | · | 35.4% | 52.4% | 72.1% | · | 76.2% | 73.5% | 66.4% | · | 82.5% | |
| Operating Margin | -2290.4% | -568.3% | · | -311.2% | -804.9% | -180.7% | · | -258.0% | -82.5% | -61.7% | · | -146.3% | -343.2% | -298.0% | · | -952.6% | |
| Net Margin | -2049.8% | -585.3% | · | 70.6% | -803.9% | -243.4% | · | -265.4% | -84.2% | -63.8% | · | -158.7% | -365.3% | -309.9% | · | -984.5% | |
| Pretax Margin | -2050.6% | -580.2% | · | 75.5% | -791.3% | -242.0% | · | -264.6% | -83.7% | -63.1% | · | -158.1% | -360.9% | -309.3% | · | -969.1% | |
| EBITDA Margin | -2290.4% | -535.1% | · | -311.2% | -804.9% | -178.9% | · | -258.0% | -82.5% | -61.7% | · | -146.3% | -343.2% | -297.7% | · | -952.6% | |
| ROA | -10.9% | -9.1% | · | 1.7% | -13.9% | -9.9% | · | -16.6% | -14.4% | -10.7% | · | -11.6% | -20.7% | -17.6% | · | -12.8% | |
| ROE | -13.8% | -11.3% | · | 2.3% | -18.3% | -12.7% | · | -30.4% | -34.4% | -20.6% | · | -18.5% | -40.5% | -29.4% | · | -16.1% | |
| ROIC | -17.8% | -11.7% | · | -5.0% | -10.0% | -5.2% | · | -52.0% | -23.9% | -16.4% | · | -14.3% | -87.7% | -48.0% | · | -29.8% |
Likidite ve Solventlik 3
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.7 | 0.9 | · | 0.9 | 1.1 | 0.5 | · | 1.7 | 2.1 | 2.4 | · | 3.0 | 1.5 | 2.0 | · | 2.9 | |
| Quick Ratio | 0.2 | 0.4 | · | 0.6 | 0.6 | 0.1 | · | 0.7 | 1.0 | 1.3 | · | 1.6 | 0.1 | 0.7 | · | 1.3 | |
| Interest Coverage | · | · | · | · | -27.6 | -34.9 | · | -29.4 | -19.8 | -16.7 | · | -19.1 | -30.6 | -31.0 | · | · |
Verimlilik 3
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.1 | 0.2 | 0.2 | · | 0.1 | 0.1 | 0.1 | · | 0.0 | |
| Inventory Turnover | 0.2 | 0.3 | · | 0.2 | 0.2 | 0.3 | · | 0.1 | 0.1 | 0.1 | · | 0.0 | 0.0 | 0.1 | · | 0.0 | |
| Receivables Turnover | 1.5 | 1.9 | · | 1.7 | 1.6 | 2.9 | · | 1.2 | 2.9 | 4.4 | · | 3.6 | 1.8 | 3.7 | · | 0.8 |
Değerleme (TTM) 10
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2M | $3M | · | $3M | $3M | $3M | · | $3M | $2M | $2M | · | $1M | $1M | $1M | · | $1M | |
| Net Income TTM | $-12M | $-9M | · | $-7M | $-8M | $-5M | · | $-3M | $-3M | $-3M | · | $-4M | $-4M | $-4M | · | $-10M | |
| Market Cap | $4M | $9M | · | $6M | $7M | $25M | · | $187M | $214M | $276M | · | · | · | · | · | · | |
| P/E | -0.0 | -0.1 | · | -3.7 | -0.3 | -1.4 | · | -2.3 | -3.0 | 154.7 | · | · | · | · | · | · | |
| P/S | 2.0 | 3.0 | · | 2.2 | 2.7 | 8.0 | · | 72.9 | 86.1 | 136.0 | · | · | · | · | · | · | |
| P/B | 0.1 | 0.3 | · | 0.1 | 0.2 | 0.7 | · | 100.1 | 75.5 | 78.7 | · | · | · | · | · | · | |
| P / Tangible Book | · | · | · | · | · | · | · | 100.1 | 75.5 | 78.7 | · | · | · | · | · | · | |
| P / Cash Flow | · | -2.0 | · | · | · | -18.6 | · | · | · | -476.1 | · | · | · | · | · | · | |
| P / FCF | · | -2.0 | · | · | · | -18.6 | · | · | · | -475.3 | · | · | · | · | · | · | |
| Earnings Yield | -2097.1% | -1626.9% | · | -27.0% | -299.8% | -71.5% | · | -42.8% | -33.6% | 0.65% | · | · | · | · | · | · |
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
Gelir Tablosu
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Gelir | $3M | $3M | $2M | $752.0K | $2M |
| Brüt Kâr Marjı % | 6.0% | 59.0% | — | 22.2% | — |
| Faaliyet Kâr Marjı % | -896.6% | -140.0% | — | -666.5% | — |
| Net Gelir | $-18M | $-4M | $-4M | $-5M | $-14M |
| Seyreltilmiş Hisse Başı Kâr | $-26.69 | $-137.30 | $-23.32 | $-3.84 | — |
Bilanço
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Cari Oran | 1.1 | 1.2 | — | 2.4 | — |
| Cari Oran | 0.7 | 0.3 | — | 1.2 | — |
Nakit Akışı
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $-9M | $-3M | — | $-7M | — |
Son Haberler Bu şirketten bahseden son manşetler
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
📊
Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kurumsal Sahipler (13F) 13 dosya · $28K toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 8 (-2 önceki Ç'ye göre) | 6 (+3 önceki Ç'ye göre) | 1 (0 önceki Ç'ye göre) | 1 (0 önceki Ç'ye göre) | +187K |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | $7.636 | 14.828 | 27,08% | Hisse senetleri |
| JANE STREET GROUP, LLC | $6.556 | 12.730 | 23,25% | Hisse senetleri |
| TWO SIGMA SECURITIES, LLC | $5.294 | 10.279 | 18,77% | Hisse senetleri |
| OSAIC HOLDINGS, INC. | $5.150 | 10.000 | 18,26% | Hisse senetleri |
| Tower Research Capital LLC (TRC) | $2.462 | 4.781 | 8,73% | Hisse senetleri |
| Global Retirement Partners, LLC | $824 | 1.600 | 2,92% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $97 | 189 | 0,34% | Hisse senetleri |
| HRT FINANCIAL LP | $59 | 115.579 | 0,21% | Hisse senetleri |
| Virtu Financial LLC | $49 | 95.296 | 0,17% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $44 | 85 | 0,16% | Hisse senetleri |
| WELLS FARGO & COMPANY/MN | $23 | 45 | 0,08% | Hisse senetleri |
| SBI Securities Co., Ltd. | $8 | 15 | 0,03% | Hisse senetleri |
| Caitong International Asset Management Co., Ltd | $1 | 1 | 0,00% | Hisse senetleri |
Şirket yöneticileri 8 içeriden öğrenenler · 2 yöneticiler · 7 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Brian M Murphy | Chief Executive Officer | 14 Kasım 2016 A | — | 0 | 0 | $0 |
| William Stern | President | 19 Ekim 2016 A | — | 0 | 0 | $0 |
| Martin M Goldstein | Yönetim kurulu üyesi | 04 Aralık 2019 A | — | 0 | 0 | $0 |
| Michael Ferguson | Yönetim kurulu üyesi | 04 Aralık 2019 A | — | 0 | 0 | $0 |
| Thomas Mika | Yönetim kurulu üyesi | 04 Aralık 2019 A | — | 0 | 0 | $0 |
| Christopher M Fashek | Yönetim kurulu üyesi | 14 Ekim 2016 A | — | 0 | 0 | $0 |
| Ira A Greenstein | Yönetim kurulu üyesi | 18 Temmuz 2016 A | — | 0 | 0 | $0 |
| Glibert Christian Michael | — | 22 Haziran 2026 S | 0 | 0 | 1 | $-144.900 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
Aktivistler ve %5+ sahipler 2 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| Glibert Christian Michael ×3 başvurular | 22 Haziran 2026 | 0,00% | Değişiklik | — | SEC |
| Rennova Health, Inc. (f/k/a CollabRx, Inc.) ×2 başvurular | 21 Şubat 2018 | — | İlk başvuru | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF sahipliği 1 ETF tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| VXF · VANGUARD INDEX FUNDS | — | — | 15 Temmuz 2026 | Günlük |